Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neoplasm Metastasis × zanidatamab × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 5 Breast Neoplasms 4 Stomach Neoplasms 3 Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Sarcoma 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Muscle Invasive Bladder Cancer (MIBC) 1 Hemangiosarcoma 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Transitional Cell 1

Interventions

Oxaliplatin 56 Capecitabine 55 Fluorouracil 51 Bevacizumab 49 Gemcitabine 44 Paclitaxel 43 Leucovorin 43 Carboplatin 36 Nivolumab 35 Irinotecan 33 Docetaxel 33 pembrolizumab 32 Cisplatin 30 Cetuximab 30 Trastuzumab 21 Radiosurgery 21 Cyclophosphamide 20 Sunitinib 19 Panitumumab 18 Doxorubicin 18 Radiotherapy 17 Interleukin-2 16 Pemetrexed 15 Fulvestrant 15 Everolimus 15 Drug Therapy 15 Ipilimumab 14 atezolizumab 13 Sorafenib 13 Albumin-Bound Paclitaxel 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07176312 2026-02-04

ZANGEA

Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest

Phase 2 Recruiting

Gastrointestinal

Neoplasm Metastasis, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡